Search

Author/Creator Beach, CL

1. Achievement of red blood cell transfusion independence in red blood cell transfusion-dependent patients with lower-risk non-del(5q) myelodysplastic syndromes correlates with serum erythropoietin levels. Issue 6 (11th May 2020)

Authors:
Santini, Valeria; Almeida, Antonio; Giagounidis, Aristoteles; Skikne, Barry; Beach, CL; Weaver, Jerry; Tu, Nora; Fenaux, Pierre
Journal:
Leukemia & lymphoma
Issue:
Volume 61:Issue 6(2020)
Page Start:
1475
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. CC-486 (oral azacitidine) in patients with myelodysplastic syndromes with pretreatment thrombocytopenia. (September 2018)

Authors:
Garcia-Manero, Guillermo; Scott, Bart L.; Cogle, Christopher R.; Boyd, Thomas E.; Kambhampati, Suman; Hetzer, Joel; Dong, Qian; Kumar, Keshava; Ukrainskyj, Stacey M.; Beach, CL; Skikne, Barry S.
Journal:
Leukemia research
Issue:
Volume 72(2018)
Page Start:
79
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Efficacy, safety, and pharmacokinetics of subcutaneous azacitidine in Taiwanese patients with higher‐risk myelodysplastic syndromes. Issue 5 (25th January 2017)

Authors:
Chou, Wen‐Chien; Yeh, Su‐Peng; Hsiao, Liang‐Tsai; Lin, Sheng‐Fung; Chen, Yeu‐Chin; Chen, Tsai‐Yun; Laille, Eric; Galettis, Anoula; Dong, Qian; Songer, Steve; Beach, CL
Journal:
Asia-Pacific journal of clinical oncology
Issue:
Volume 13:Issue 5(2017)
Page Start:
e430
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗